For: |
Sheen IS, Jeng KS, Wu JY. Is |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i6/1202.htm |
Number | Citing Articles |
1 |
Xinguo Chen, Jing Xu, Peixiao Wang, Lei Shang, Jing Guo, Lihong Huang, Yide A. Jiang, Jinhong Chen, Huijuan Chen, Yukui Shang, Qing Zhang. Metallophosphoesterase 1, a novel candidate gene in hepatocellular carcinoma malignancy and recurrence. Cancer Biology & Therapy 2020; 21(11): 1005 doi: 10.1080/15384047.2020.1824480
|
2 |
Ashish Singhal, Muralidharan Jayaraman, Danny N. Dhanasekaran, Vivek Kohli. Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence. Critical Reviews in Oncology/Hematology 2012; 82(2): 116 doi: 10.1016/j.critrevonc.2011.05.005
|
3 |
Shugo Suzuki, Pornsiri Pitchakarn, Kumiko Ogawa, Aya Naiki-Ito, Teera Chewonarin, Wanisa Punfa, Makoto Asamoto, Tomoyuki Shirai, Satoru Takahashi. Expression of glutathione peroxidase 2 is associated with not only early hepatocarcinogenesis but also late stage metastasis. Toxicology 2013; 311(3): 115 doi: 10.1016/j.tox.2013.07.005
|
4 |
Omneya Y. Bassyoni, Hiam A. Eleleimy, Eman A. Saad. Significance of p53, cyclooxygenase-2, and epithelial cell adhesion molecule expression in hepatocellular carcinoma: an immunohistochemical study. Egyptian Journal of Pathology 2024; 44(1): 39 doi: 10.4103/egjp.egjp_10_24
|
5 |
Ray-Hwang Yuan, Yung-Ming Jeng, Hung-Wei Pan, Fu-Chang Hu, Po-Lin Lai, Po-Huang Lee, Hey-Chi Hsu. Overexpression of KIAA0101 Predicts High Stage, Early Tumor Recurrence, and Poor Prognosis of Hepatocellular Carcinoma. Clinical Cancer Research 2007; 13(18): 5368 doi: 10.1158/1078-0432.CCR-07-1113
|
6 |
César López-Camarillo, Elena Aréchaga Ocampo, Mavil López Casamichana, Carlos Pérez-Plasencia, Elizbeth Álvarez-Sánchez, Laurence A. Marchat. Protein Kinases and Transcription Factors Activation in Response to UV-Radiation of Skin: Implications for Carcinogenesis. International Journal of Molecular Sciences 2011; 13(1): 142 doi: 10.3390/ijms13010142
|
7 |
Subramaniam Mohana Devi, Vellingiri Balachandar, Meyyazhagan Arun, Shanmugam Suresh Kumar, Balasubramanian Balamurali Krishnan, Keshavarao Sasikala. Analysis of Genetic Damage and Gene Polymorphism in Hepatocellular Carcinoma (HCC) Patients in a South Indian Population. Digestive Diseases and Sciences 2013; 58(3): 759 doi: 10.1007/s10620-012-2409-8
|
8 |
R‐H Yuan, Y‐M Jeng, H‐L Chen, P‐L Lai, H‐W Pan, F‐J Hsieh, C‐Y Lin, P‐H Lee, H‐C Hsu. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma. The Journal of Pathology 2006; 209(4): 549 doi: 10.1002/path.2011
|
9 |
Kenji Yorita, Akinobu Ohno, Hiroaki Kataoka. Emerging histopathological prognostic biomarkers in hepatocellular carcinomas. Personalized Medicine Universe 2014; 3: 15 doi: 10.1016/j.pmu.2014.03.006
|
10 |
Richard A. Burkhart, Sean M. Ronnekleiv-Kelly, Timothy M. Pawlik. Personalized therapy in hepatocellular carcinoma: Molecular markers of prognosis and therapeutic response. Surgical Oncology 2017; 26(2): 138 doi: 10.1016/j.suronc.2017.01.009
|
11 |
M Guido, T Roskams, P Pontisso, M Fassan, S N Thung, L Giacomelli, A Sergio, F Farinati, U Cillo, M Rugge. Squamous cell carcinoma antigen in human liver carcinogenesis. Journal of Clinical Pathology 2008; 61(4): 445 doi: 10.1136/jcp.2007.051383
|
12 |
S. GIANNI, A. CECCHETTO, G. ALTAVILLA, R. RAGAZZI, M. BERTAZZO, M. DE GIORGIO, A. BALDAN, S. FAGIUOLI, F. FARINATI. Tumour staging, morphology and p53 overexpression concur in predicting survival in hepatocellular carcinoma. Journal of Internal Medicine 2005; 257(4): 367 doi: 10.1111/j.1365-2796.2005.01460.x
|
13 |
Gihan Hosny, Nahla Farahat, Hanan Tayel, Pierre Hainaut. Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseases. Cancer Letters 2008; 264(2): 201 doi: 10.1016/j.canlet.2008.01.031
|
14 |
Surong Hu, Lianying Zhao, Jingting Yang, Miao Hu. The association between polymorphism of P53 Codon72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3,704 cases. Tumor Biology 2014; 35(4): 3647 doi: 10.1007/s13277-013-1483-7
|
15 |
Yoon Jun Kim, Hyo-Suk Lee. Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection. The Korean Journal of Hepatology 2009; 15(1): 7 doi: 10.3350/kjhep.2009.15.1.7
|
16 |
D.S.R. Lockwood, D.C. Gotley. Integration/Interaction of Oncologic Growth. Cancer Growth and Progression 2005; 15: 165 doi: 10.1007/1-4020-3414-8_9
|
17 |
Xiao-Jia Yu, Fang Fang, Chun-Lei Tang, Lei Yao, Lu Yu, Long Yu. dbHCCvar: A comprehensive database of human genetic variations in hepatocellular carcinoma. Human Mutation 2011; 32(12): E2308 doi: 10.1002/humu.21595
|
18 |
Meng-Sen Li, Ping-Feng Li, Qian Chen, Guo-Guang Du, Gang Li. Alpha-fetoprotein stimulated the expression of some oncogenes in human hepatocellular carcinoma Bel 7402 cells. World Journal of Gastroenterology 2004; 10(6): 819-824 doi: 10.3748/wjg.v10.i6.819
|
19 |
Zhen Zhang, Hanyu Jiang, Jie Chen, Yi Wei, Likun Cao, Zheng Ye, Xin Li, Ling Ma, Bin Song. Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction. Cancer Imaging 2019; 19(1) doi: 10.1186/s40644-019-0209-5
|
20 |
Christopher D. Mann, Christopher P. Neal, Giuseppe Garcea, Margaret M. Manson, Ashley R. Dennison, David P. Berry. Prognostic molecular markers in hepatocellular carcinoma: A systematic review. European Journal of Cancer 2007; 43(6): 979 doi: 10.1016/j.ejca.2007.01.004
|
21 |
Mia Kumar, Xuelian Zhao, Xin Wei Wang. Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine?. Cell & Bioscience 2011; 1(1) doi: 10.1186/2045-3701-1-5
|
22 |
Matlola Bopape, Charlette Tiloke, Claudia Ntsapi.
Moringa oleifera
and Autophagy: Evidence from
In Vitro
Studies on Chaperone-Mediated Autophagy in HepG
2
Cancer Cells
. Nutrition and Cancer 2023; 75(10): 1822 doi: 10.1080/01635581.2023.2270215
|
23 |
Min Luo, Fan Yang, Sheng-xin Huang, Zhi-peng Kuang, Xiao-ling Luo, Yuan-dong Li, Ji-ning Wu, Yu-an Xie. Two-Stage Model of Chemically Induced Hepatocellular Carcinoma in Mouse. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2012; 20(11): 517 doi: 10.3727/096504013X13747716581336
|